Status:
COMPLETED
A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss
Lead Sponsor:
Johnson & Johnson Consumer and Personal Products Worldwide
Conditions:
Androgenetic Alopecia
Eligibility:
MALE
15-49 years
Phase:
PHASE3
Brief Summary
The primary purpose of the study is to evaluate the efficacy of a topical 5% minoxidil formulation in males for the treatment of pattern hair loss. The secondary purpose is to evaluate the safety of a...
Detailed Description
Male subjects with androgenetic alopecia were enrolled in this fourteen-center trial. Subjects were randomized to use either 5% minoxidil or placebo foam twice daily for 16 weeks. A total of 143 subje...
Eligibility Criteria
Inclusion
- presence of androgenetic alopecia with vertex pattern IIIv, IV, or V on the Norwood Hamilton Scale
- Male sex, age 15 to 49, good health
- Willingness to have a dot tattoo placed in the target area of the scalp during the study
- Willingness to maintain normal shampooing habits and products during the study
- Willingness to maintain the same hair style, approximate length, and hair color throughout the study
Exclusion
- Known sensitivity to the investigational product
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2004
Estimated Enrollment :
352 Patients enrolled
Trial Details
Trial ID
NCT00151515
Start Date
October 1 2003
End Date
July 1 2004
Last Update
September 30 2016
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
La Jolla, California, United States, 92037
2
Pfizer Investigational Site
San Francisco, California, United States, 94102
3
Pfizer Investigational Site
Vallejo, California, United States, 94503
4
Pfizer Investigational Site
Denver, Colorado, United States, 80012